Trial intelligence / Profile preview

Rapid Acclimatization to Hypoxia at Altitude

NCT01702025Phase 2Completed

Sponsor
Colorado State University
Start
Jun 2012
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of methazolamide and aminophylline in acute mountain sickness (AMS) (4 arms), sponsored by Colorado State University. Primary endpoint: Magnitude of Decrement in Exercise Time Trial Performance in Hypoxia Compared With Normoxia. Started Jun 2012; status: completed.

02

Drugs

methazolamideaminophylline
03

Conditions

acute mountain sickness (AMS)

Beyond the preview

Go deeper on NCT01702025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01702025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call